Scholars@Duke

Response to: 'Lack of standardization of ANA and implications for drug development and precision medicine' by Mahler.

Publication ,  Journal Article
Pisetsky, DS; Spencer, DM; Lipsky, PE; Rovin, BH
Published in: Ann Rheum Dis
May 2019
Published version (DOI) Link to item

Duke Scholars

David Stephen Pisetsky
Author David Stephen Pisetsky Medicine, Rheumatology and Immunology

Published In

Ann Rheum Dis

DOI

10.1136/annrheumdis-2018-213399

EISSN

1468-2060

Publication Date

May 2019

Volume

78

Issue

5

Start / End Page

e34

Location

England

Related Subject Headings

  • Reference Standards
  • Precision Medicine
  • Patients
  • Humans
  • Drug Development
  • Arthritis & Rheumatology
  • Antibodies, Antinuclear
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pisetsky, D. S., Spencer, D. M., Lipsky, P. E., & Rovin, B. H. (2019). Response to: 'Lack of standardization of ANA and implications for drug development and precision medicine' by Mahler. Ann Rheum Dis, 78(5), e34. https://doi.org/10.1136/annrheumdis-2018-213399
Pisetsky, David S., Diane M. Spencer, Peter E. Lipsky, and Brad H. Rovin. “Response to: 'Lack of standardization of ANA and implications for drug development and precision medicine' by Mahler.” Ann Rheum Dis 78, no. 5 (May 2019): e34. https://doi.org/10.1136/annrheumdis-2018-213399.
Pisetsky DS, Spencer DM, Lipsky PE, Rovin BH. Response to: 'Lack of standardization of ANA and implications for drug development and precision medicine' by Mahler. Ann Rheum Dis. 2019 May;78(5):e34.
Pisetsky, David S., et al. “Response to: 'Lack of standardization of ANA and implications for drug development and precision medicine' by Mahler.” Ann Rheum Dis, vol. 78, no. 5, May 2019, p. e34. Pubmed, doi:10.1136/annrheumdis-2018-213399.
Pisetsky DS, Spencer DM, Lipsky PE, Rovin BH. Response to: 'Lack of standardization of ANA and implications for drug development and precision medicine' by Mahler. Ann Rheum Dis. 2019 May;78(5):e34.

Published In

Ann Rheum Dis

DOI

10.1136/annrheumdis-2018-213399

EISSN

1468-2060

Publication Date

May 2019

Volume

78

Issue

5

Start / End Page

e34

Location

England

Related Subject Headings

  • Reference Standards
  • Precision Medicine
  • Patients
  • Humans
  • Drug Development
  • Arthritis & Rheumatology
  • Antibodies, Antinuclear
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services